We used fluorescence immunohistochemistry (F-IHC) to examine expression of OLIG2, a progenitor marker that was expressed in a majority of PA cancer cells based on scRNA-seq, and of GFAP, a top marker of the AC-like gene programme, in the context of the PA tumor architecture (Fig. 6a, b). The gene discussed is OLIG2; the disease is cancer.